The appointed probity adviser has performed the same role for virtually every PBS policy process since 2015, including the negotiation of the past two pharmacy agreements, the $6.6 billion reform package in 2015, the government's current agreements with MA and the GBMA, and the HTA review.
Health department confirms the appointment of probity adviser for 8CPA negotiation
October 5, 2023 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Taylor confirms Anne Ruston will retain health portfolio in opposition reshuffle
February 17, 2026 - - Latest News -
Minister confirms PBS listing for new cystic fibrosis therapy and funded access to other medicines
February 16, 2026 - - Latest News -
Director pay rises across ASX healthcare sector, but gender balance remains uneven
February 16, 2026 - - Latest News -
Life sciences sector unites to advance women’s leadership at landmark 2026 events
February 16, 2026 - - Latest News -
New imaging agent shows stronger detection of recurrent prostate cancer in head-to-head trial
February 16, 2026 - - Australian Biotech -
Medibank funding expansion signals momentum for Emyria’s mental health model
February 16, 2026 - - Latest News -
IMF pours cold water on fears of US pharmaceutical tariffs as pressures shift to care spending
February 16, 2026 - - Latest News

